Table 2.

Changes in bone biomarker levels during different anti-osteoporosis therapeutic regimes

Bone marker	Type	Therapy	Target levels	Follow-up period
ß Crosslaps	Resorption marker	Anti-resorptive	min. 35% ↓	Baseline and every 6 months
Total P1NP	Formation marker	Anti-resorptive	min. 40% ↓	Baseline and every 6 months
		Anabolic	min. 40% ↓	Baseline and every 6 months
Osteocalcin	Turnover marker	Anti-resorptive	min. 20% ↓	Baseline and every 6 months